(Q38552402)

PubMed ID

26202377

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202377%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer (English)

1 reference

PubMed ID

26202377

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202377%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

William Ka-Kei Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

author name string

Xin Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

Zheng Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

Jun Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

publication date

22 July 2015

1 reference

PubMed ID

26202377

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202377%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

page(s)

503-510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

cites work

Global cancer statistics

1 reference

Increasing incidence of colorectal cancer in Asia: implications for screening

21 January 2018

1 reference

A systematic review of treatment guidelines for metastatic colorectal cancer

21 January 2018

1 reference

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

21 January 2018

1 reference

Methods of overcoming treatment resistance in colorectal cancer.

21 January 2018

1 reference

MicroRNA in colorectal cancer: from benchtop to bedside

21 January 2018

1 reference

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

The emerging role of microRNAs in regulating immune and inflammatory responses in the lung.

21 January 2018

1 reference

MicroRNAs and their roles in aging.

21 January 2018

1 reference

microRNAs in inflammation

21 January 2018

1 reference

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

21 January 2018

1 reference

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

21 January 2018

Capecitabine: a review

1 reference

Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells

21 January 2018

1 reference

Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells

21 January 2018

1 reference

Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.

21 January 2018

1 reference

The autophagic paradox in cancer therapy

21 January 2018

1 reference

MicroRNA profiling in human colon cancer cells during 5-fluorouracil-induced autophagy

21 January 2018

1 reference

MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.

21 January 2018

1 reference

Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer

21 January 2018

1 reference

miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.

21 January 2018

1 reference

miRNA-497 Enhances the Sensitivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeutic Drug

21 January 2018

1 reference

A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs.

21 January 2018

1 reference

Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness

21 January 2018

1 reference

Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells

21 January 2018

1 reference

TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells

21 January 2018

1 reference

MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells

21 January 2018

1 reference

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.

21 January 2018

1 reference

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

21 January 2018

1 reference

Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo

21 January 2018

1 reference

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer

21 January 2018

1 reference

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer

21 January 2018

1 reference

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene

21 January 2018

1 reference

Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.

21 January 2018

1 reference

MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells

21 January 2018

1 reference

Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells

21 January 2018

1 reference

Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro

21 January 2018

1 reference

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

21 January 2018

1 reference

Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens

21 January 2018

1 reference

MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

21 January 2018

1 reference

MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer

21 January 2018

1 reference

p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest

21 January 2018

1 reference

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

21 January 2018

1 reference

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms

21 January 2018

1 reference

Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.

21 January 2018

1 reference

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding

21 January 2018

1 reference

Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines.

21 January 2018

1 reference

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

21 January 2018

1 reference

MiR-320e is a novel prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer

21 January 2018

1 reference

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

21 January 2018

1 reference

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.

21 January 2018

1 reference

Predicting distant metastasis and chemoresistance using plasma miRNAs.

21 January 2018

1 reference

Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer

21 January 2018

1 reference

Oxaliplatin: a review in the era of molecularly targeted therapy

21 January 2018

1 reference

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

21 January 2018

1 reference

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

21 January 2018

1 reference

miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines

21 January 2018

1 reference

LIN28B promotes colon cancer migration and recurrence

21 January 2018

1 reference

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

21 January 2018

1 reference

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

21 January 2018

1 reference

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.

21 January 2018

1 reference

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

21 January 2018

1 reference

Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy.

21 January 2018

1 reference

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity

21 January 2018

1 reference

Irinotecan induces senescence and apoptosis in colonic cells in vitro

21 January 2018

1 reference

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

21 January 2018

1 reference

Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan

21 January 2018

1 reference

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease

21 January 2018

1 reference

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan

21 January 2018

1 reference

Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil

21 January 2018

1 reference

12 December 2020

Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer.

1 reference

12 December 2020

Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer.

1 reference

12 December 2020

Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells

1 reference

12 December 2020

Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan

1 reference

12 December 2020

MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF

1 reference

12 December 2020

Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases

1 reference

12 December 2020

MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells

1 reference

12 December 2020

MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells.

1 reference

12 December 2020

miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer

1 reference

12 December 2020

Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

1 reference

12 December 2020

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

1 reference

12 December 2020

5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro

1 reference

12 December 2020

Visualising and quantifying angiogenesis in metastatic colorectal cancer : A comparison of methods and their predictive value for chemotherapy response

1 reference

12 December 2020

Identifiers

DOI

10.1111/CPR.12202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496401&resulttype=core&format=json

14 May 2020

1 reference